We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIO market cap is 8.05B. The company's latest EPS is USD -22.3478 and P/E is -12.68.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 676.84M | 681.11M | 632.12M | 681.18M | 610.82M |
| Operating Income | 61.91M | 89.62M | 90.95M | 95.32M | 44.71M |
| Net Income | 68.96M | -1.16B | -476.67M | 932.64M | 383.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.31B | 2.55B | 2.92B | 2.8B | 2.67B |
| Operating Income | 229.66M | 410.96M | 489.43M | 475.12M | 337.8M |
| Net Income | 1.76B | 3.81B | 4.25B | -3.63B | -637.32M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.67B | 11.98B | 11.9B | 12.3B | 12.61B |
| Total Liabilities | 3.9B | 3.53B | 3.48B | 3.56B | 3.56B |
| Total Equity | 9.76B | 8.45B | 8.42B | 8.74B | 9.05B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.01B | 12.97B | 17.78B | 13.5B | 12.3B |
| Total Liabilities | 2.25B | 3.09B | 4.11B | 3.89B | 3.56B |
| Total Equity | 5.76B | 9.88B | 13.67B | 9.62B | 8.74B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 98.12M | 196.19M | 293.9M | 374.94M | 69.79M |
| Investing | -70.47M | -42.49M | -51.99M | 20.21M | -43.09M |
| Financing | 4.31M | -198.43M | -225.03M | -425.65M | 21k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 457.9M | 575.33M | 656.52M | 194.45M | 374.94M |
| Investing | -208.89M | -60.25M | -784.44M | -1.21B | 20.21M |
| Financing | -22.76M | -523.04M | -55.43M | 973.58M | -425.65M |
| Market Cap | 8.05B |
| Price to Earnings Ratio | -12.68 |
| Price to Sales Ratio | 3.03 |
| Price to Cash Ratio | 20.02 |
| Price to Book Ratio | 0.92 |
| Dividend Yield | - |
| Shares Outstanding | 28.52M |
| Average Volume (1 week) | 217.01k |
| Average Volume (1 Month) | 211.69k |
| 52 Week Change | -25.16% |
| 52 Week High | 431.79 |
| 52 Week Low | 261.59 |
| Spread (Intraday) | 29.2 (9.9%) |
| Company Name | Bio Rad Laboratories Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bio-rad.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
